Tryptophan depletion decreases the recognition of fear in female volunteers

RationaleSerotonergic processes have been implicated in the modulation of fear conditioning in humans, postulated to occur at the level of the amygdala. The processing of other fear-relevant cues, such as facial expressions, has also been associated with amygdala function, but an effect of serotonin depletion on these processes has not been assessed.ObjectiveThe present study investigated the effects of reducing serotonin function, using acute tryptophan depletion, on the recognition of basic facial expressions of emotions in healthy male and female volunteers.MethodsA double-blind between-groups design was used, with volunteers being randomly allocated to receive an amino acid drink specifically lacking tryptophan or a control mixture containing a balanced mixture of these amino acids. Participants were given a facial expression recognition task 5 h after drink administration. This task featured examples of six basic emotions (fear, anger, disgust, surprise, sadness and happiness) that had been morphed between each full emotion and neutral in 10% steps. As a control, volunteers were given a famous face classification task matched in terms of response selection and difficulty level.ResultsTryptophan depletion significantly impaired the recognition of fearful facial expressions in female, but not male, volunteers. This was specific since recognition of other basic emotions was comparable in the two groups. There was also no effect of tryptophan depletion on the classification of famous faces or on subjective state ratings of mood or anxiety.ConclusionsThese results confirm a role for serotonin in the processing of fear related cues, and in line with previous findings also suggest greater effects of tryptophan depletion in female volunteers. Although acute tryptophan depletion does not typically affect mood in healthy subjects, the present results suggest that subtle changes in the processing of emotional material may occur with this manipulation of serotonin function.

[1]  P. Ekman.  Pictures of Facial Affect , 1976 .

[2]  H. Nelson,et al.  Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.

[3]  P. Cowen,et al.  Dieting changes serotonergic function in women, not men: implications for the aetiology of anorexia nervosa? , 1987, Psychological Medicine.

[4]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[5]  P. Cowen,et al.  Plasma concentrations of tryptophan and dieting. , 1990, BMJ.

[6]  J. Deakin.  Depression and 5HT , 1991, International clinical psychopharmacology.

[7]  D. Perrett,et al.  A differential neural response in the human amygdala to fearful and happy facial expressions , 1996, Nature.

[8]  Peggy Dean,et al.  Mood Response to Acute Tryptophan Depletion in Healthy Volunteers: Sex Differences and Temporal Stability , 1996, Neuropsychopharmacology.

[9]  D. Perrett,et al.  Facial expression megamix: Tests of dimensional and category accounts of emotion recognition , 1997, Cognition.

[10]  A. Young,et al.  Rapid depletion of plasma tryptophan: a review of studies and experimental methodology , 1997, Journal of psychopharmacology.

[11]  KA Smith,et al.  Relapse of depression after rapid depletion of tryptophan , 1997, The Lancet.

[12]  R. Salomon,et al.  Lack of behavioral effects of monoamine depletion in healthy subjects , 1997, Biological Psychiatry.

[13]  R. Adolphs.  Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala , 1997 .

[14]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Graeff,et al.  Dual role of 5-HT in defense and anxiety , 1997, Neuroscience & Biobehavioral Reviews.

[16]  J. Gorman,et al.  Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety , 1998, Biological Psychiatry.

[17]  S. Maier,et al.  Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat , 1998, Brain Research.

[18]  T. Koyama,et al.  Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. , 1999, European journal of pharmacology.

[19]  J. Deakin,et al.  Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans , 1999, Journal of psychopharmacology.

[20]  A. Young,et al.  Recognition of facial emotion in nine individuals with bilateral amygdala damage , 1999, Neuropsychologia.

[21]  Michael Davis,et al.  The amygdala: vigilance and emotion , 2001, Molecular Psychiatry.

[22]  G. Bagdy,et al.  Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. , 2001, The international journal of neuropsychopharmacology.

[23]  Stephen Maren.  Neurobiology of Pavlovian fear conditioning. , 2001, Annual review of neuroscience.

[24]  W. Drevets,et al.  The cellular neurobiology of depression , 2001, Nature Medicine.

[25]  M. Ebert,et al.  Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT3 receptor antagonist, in the mouse elevated plus-maze , 2001, Pharmacology Biochemistry and Behavior.

[26]  Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze. , 2001, Pharmacology, biochemistry, and behavior.

[27]  A. V. D. Does,et al.  The effects of tryptophan depletion on mood and psychiatric symptoms. , 2001 .

[28]  F. Graeff,et al.  Opposite effects of nefazodone in two human models of anxiety , 2001, Psychopharmacology.

[29]  D. Marazziti,et al.  Do animal models of anxiety predict anxiolytic-like effects of antidepressants? , 2002, Psychopharmacology.

[30]  P. Cowen,et al.  Repeated administration of citalopram or reboxetine reduces the perception of negative emotions from facial expression. , 2002 .

[31]  G. Higgins,et al.  Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety , 2002, Pharmacology Biochemistry and Behavior.

[32]  D. Perrett,et al.  Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers , 2003, Neuropsychopharmacology.

[33]  J. Deakin,et al.  Effects of ritanserin on aversive classical conditioning in humans , 2005, Psychopharmacology.